Beijing Aosaikang Pharmaceutical (002755.SZ) Earnings Analysis

Beijing Aosaikang Pharmaceutical (002755.SZ) has no confirmed upcoming earnings date. Trailing P/E 46.19.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 002755.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 002755.SZ. This page updates as the calendar is published.

002755.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-10-290.06823 CNYn/an/an/a
2025-04-280.03585 CNYn/an/an/a
2025-03-310.06 CNYn/an/an/a
2024-08-290.04746 CNYn/an/an/a

002755.SZ valuation and analyst view

Trailing P/E46.19
Trailing EPS0.28378 CNY
Price / book3.71
Dividend yield0.92%
Market cap12.22B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Beijing Aosaikang Pharmaceutical (002755.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 002755.SZ. This page updates as the calendar is published.

Did 002755.SZ beat earnings last quarter?

Consensus estimate data was not available for 002755.SZ's 2025-10-29 report.

What is 002755.SZ's current P/E ratio and EPS?

002755.SZ trades at a trailing P/E of 46.19 on trailing EPS of 0.2837813793327429 CNY.

What do analysts rate 002755.SZ?

002755.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.